Neuralstem (CUR) Misses Q4 EPS by 1c
Get Alerts CUR Hot Sheet
Price: $1.52 --0%
Financial Fact:
Interest expense: -240.46K
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Interest expense: -240.46K
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Neuralstem (NASDAQ: CUR) reported Q4 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06).
Cash, cash equivalents and short-term investments on hand was approximately $7.6 million at March 31, 2015, compared to approximately $12.2 million at December 31, 2015. The decrease was primarily due to our ongoing operating expenses primarily related to preparations for the initiation of our NSI-189 Phase 2 clinical trial for the treatment of MDD.
For earnings history and earnings-related data on Neuralstem (CUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fox upgraded to overweight as Roku deal, ad strength lift outlook
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share